Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Study record page now displays a 403 Forbidden error instead of the expected content, blocking access to the NCT04292899 study details. The page loads an error screen rather than showing the study information and related documents.SummaryDifference17%

- Check17 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating an updated page version.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be a minor version update indicating a new build or content refresh rather than a substantive change to the page's information.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a new page release or build. No substantive content changes are evident from the provided data.SummaryDifference0.0%

- Check67 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, representing a small documentation/versioning update rather than a change to study information.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2 as part of a small site update.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.